Olga Chernoloz PhD

With a Ph.D. in Neuroscience Olga has held a number of roles in clinical trial management, drug development, biotech, and pharmaceutics. As a trained neuropharmacologist and a registered pharmacist Dr. Chernoloz, head of Omnica Biotech, helps cannabinoid space players of all sizes to guide R&D programs, run feasibility analyses and optimize business development strategy taking into consideration scientific and regulatory underpinnings. The research program for the development of cannabinoid veterinary drugs developed by her company was adopted and successfully run through clinical trials.

Dr. Chernoloz has developed and delivered educational modules for medical and adult cannabis space in both academic and business settings. Olga has designed and delivered a course in one of the first cannabis-centric college programs at AAPS and is leading the Science of Cannabis course at Ryerson University.

Her forthcoming book Cannabis A-Z is a complete guide to the place of cannabis in society, culture, and medicine. Before pivoting into the cannabinoid field, Olga specialized in mental health research authoring a number of original research articles and a chapter in an instructional book on Neurobiology of Mood Disorders.